BE884935A - APPLICATION OF 4-ARYL-2 (1H) -QUINAZOLINONES FOR THE TREATMENT OF CONDITIONS BY SELF-IMMUNIZATION OF CONNECTIVE TISSUES - Google Patents

APPLICATION OF 4-ARYL-2 (1H) -QUINAZOLINONES FOR THE TREATMENT OF CONDITIONS BY SELF-IMMUNIZATION OF CONNECTIVE TISSUES

Info

Publication number
BE884935A
BE884935A BE1/9934A BE1009939A BE884935A BE 884935 A BE884935 A BE 884935A BE 1/9934 A BE1/9934 A BE 1/9934A BE 1009939 A BE1009939 A BE 1009939A BE 884935 A BE884935 A BE 884935A
Authority
BE
Belgium
Prior art keywords
quinazolinones
immunization
aryl
self
treatment
Prior art date
Application number
BE1/9934A
Other languages
French (fr)
Original Assignee
Sandoz Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Sa filed Critical Sandoz Sa
Publication of BE884935A publication Critical patent/BE884935A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
BE1/9934A 1979-08-30 1980-08-27 APPLICATION OF 4-ARYL-2 (1H) -QUINAZOLINONES FOR THE TREATMENT OF CONDITIONS BY SELF-IMMUNIZATION OF CONNECTIVE TISSUES BE884935A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH787179 1979-08-30

Publications (1)

Publication Number Publication Date
BE884935A true BE884935A (en) 1981-02-27

Family

ID=4331669

Family Applications (1)

Application Number Title Priority Date Filing Date
BE1/9934A BE884935A (en) 1979-08-30 1980-08-27 APPLICATION OF 4-ARYL-2 (1H) -QUINAZOLINONES FOR THE TREATMENT OF CONDITIONS BY SELF-IMMUNIZATION OF CONNECTIVE TISSUES

Country Status (5)

Country Link
JP (1) JPS5636418A (en)
AU (1) AU545003B2 (en)
BE (1) BE884935A (en)
IT (1) IT1141027B (en)
PH (1) PH16864A (en)

Also Published As

Publication number Publication date
AU6183680A (en) 1981-03-19
PH16864A (en) 1984-03-22
JPS5636418A (en) 1981-04-09
AU545003B2 (en) 1985-06-27
IT1141027B (en) 1986-10-01
IT8024347A0 (en) 1980-08-28

Similar Documents

Publication Publication Date Title
BE851328A (en) COMPOSITION FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
BE859817A (en) COMPOSITIONS ESPECIALLY USEFUL FOR THE TREATMENT OF ACNE
FR2342072A1 (en) ENZYMATIC COMPOSITION FOR THE TREATMENT OF CATARACT
MA18939A1 (en) PROCESS FOR THE PREPARATION OF AN AGENT FOR THE TREATMENT OF THEILERIOSES
BE843359A (en) PREPARATION FOR THE TREATMENT OF PERIODONTOSIS
BE883096A (en) PROCESS FOR THE PREPARATION OF HIGHLY PURIFIED PROTHROMBINIC COMPLEX CONCENTRATES, CONCENTRATES OBTAINED AND THEIR APPLICATION
BE865156A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DEPRESSIONS
BE868544A (en) COMPOSITION CONTAINING DITHRANOL FOR THE TREATMENT OF PSORIASIS
RO75590A (en) PROCESS FOR THE PREPARATION OF METHYL ACRYLATE OR METHACRYLATE
BE885291A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CARDIAC DYSFUNCTION
BE885290A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERLIPIDEMIA AND HYPERLIPOPROTEINEMIA
BE872908A (en) PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF HYPERTENSION
MA20655A1 (en) COMPOSITIONS FOR THE TREATMENT OF TEXTILES
BE871753A (en) NEW THERAPEUTIC USE OF ACETYL-1-CARNITINE FOR THE TREATMENT OF HEART CONDITIONS
BE858692A (en) COMPOSITION FOR THE TREATMENT OF ACNE
BE856740A (en) NEW DRUG COMPOSITION FOR THE TREATMENT OF BILIARY LITHIASIS
RO88351A3 (en) COMPOSITION FOR THE TREATMENT OF GASTRODUODENAL DISEASES
FR2340737A1 (en) COMPOSITION FOR THE TREATMENT OF HYPERCHOLESTEROLEMIA
BE884935A (en) APPLICATION OF 4-ARYL-2 (1H) -QUINAZOLINONES FOR THE TREATMENT OF CONDITIONS BY SELF-IMMUNIZATION OF CONNECTIVE TISSUES
BE856957A (en) ELECTRODE FOR IONOPHORESIS TREATMENT
IT1143012B (en) PYRIMIDINIC 6-ARIL COMPOUNDS FOR THE TREATMENT AND PREVENTION OF VIRAL INFECTIONS AND TO STIMULATE THE PRODUCTION OF INTERFERONE
FR2544614B1 (en) NEW DRUG ASSOCIATION FOR THE TREATMENT OF HYPERTENSION
RO79428A2 (en) DRUG COMPOSITION FOR THE TREATMENT OF DERMATOSES
FR2334362A1 (en) PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HYPERURICEMIA
BE864979A (en) COMPOSITIONS FOR THE TREATMENT OF ASTHMATIC CONDITIONS

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: SANDOZ S.A.

Effective date: 19860831